Obesity in pregnancy: infant health service utilisation and costs on the NHS

Kelly L Morgan1, Muhammad A Rahman2, Rebecca A Hill2

  • 1Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, UK.

BMJ Open
|November 28, 2015
PubMed

Insights

Infants born to obese mothers incur 72% higher healthcare costs in their first year. Early pregnancy interventions to reduce maternal obesity could be cost-effective for the National Health Service.

Area of Science:

  • Public Health
  • Healthcare Economics
  • Maternal and Child Health

Background:

  • Maternal overweight and obesity are significant public health concerns.
  • The economic impact of maternal obesity on healthcare systems requires thorough investigation.

Purpose of the Study:

  • To estimate the direct healthcare costs associated with infants born to overweight or obese mothers in the UK's National Health Service (NHS).

Main Methods:

  • A retrospective, prevalence-based study utilizing linked anonymised electronic health data from the Growing Up in Wales: Environments for Healthy Living (EHL) study.
  • Infants were categorized based on maternal pre-pregnancy Body Mass Index (BMI): healthy weight (18.5–24.9 kg/m²), overweight (25–29.9 kg/m²), and obese (≥30 kg/m²).
  • Direct healthcare costs for infants from birth to one year were calculated based on health service utilization in 2012-2013.

Main Results:

  • A significant association was found between maternal BMI and infant healthcare costs (p<0.001).
  • Infants born to obese mothers incurred 72% higher mean total costs compared to those born to healthy weight mothers.
  • Additional costs were driven by increased inpatient visits (number and duration) and higher general practitioner visit frequency, with estimated additional costs of £65.13 for overweight and £1138.11 for obese mothers.

Conclusions:

  • Infants born to mothers with higher BMIs consume significantly more health service resources during their first year of life.
  • These increased costs are evident across inpatient and general practitioner services.
  • Interventions to reduce maternal obesity in early pregnancy, costing less than £2310 per person, may be cost-effective for the NHS.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K